Specialty code 174400000X · Kissimmee, FL
NPI
1982008033
Since 2014
Specialty
Specialty code 174400000X
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
737 W Oak St
Kissimmee, FL, 34741
Phone (407) 933-2775
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
6,287 services
Medicare patients, 2024
89
Average age 74
Drug cost, 2024
$4.2M
1,263 prescriptions
Company payments, 2025
$57.88
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roger Febres was code 99214 (office e&m - established), 131 times for 76 patients. In total Roger Febres billed 6,287 services in 40 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 131 | 76 | $88.02 | $12K |
| 36415 Venipuncture Blood Collection | Office | 84 | 30 | $8.65 | $727 |
| 85025 Blood Count | Office | 80 | 26 | $7.61 | $609 |
| 99233 Hospital E&M - Subsequent | Facility | 38 | 11 | $91.55 | $3,479 |
| 99204 Office E&M - New | Office | 12 | 12 | $119.29 | $1,431 |
By year: 2022 $78K for 6,032 services; 2023 $47K for 4,967 services; 2024 $41K for 6,287 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 84 | 30 | $8.65 | $727 |
| 85025 Blood Count | 80 | 26 | $7.61 | $609 |
Medicare prescription drug claims, 2024
In 2024, the drug Roger Febres prescribed most often to Medicare patients was Anastrozole, with 218 prescriptions and refills. In total Roger Febres wrote 1,263 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 218 | 391 | 52 | $3,331 |
| Prolia Denosumab | 92 | 549 | 54 | $159K |
| Exemestane Generic | 53 | 109 | 17 | $12K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 48 | 48 | 12 | $1,069 |
| Keytruda Pembrolizumab | 43 | 43 | Under 11 | $477K |
| Folic Acid Generic | 41 | 67 | 11 | $181 |
| Eliquis Apixaban | 40 | 42 | Under 11 | $23K |
| Opdivo Nivolumab | 40 | 40 | Under 11 | $210K |
| Hydroxyurea Generic | 26 | 56 | 11 | $885 |
| Kanjinti Trastuzumab-Anns | 24 | 24 | Under 11 | $81K |
| Tamoxifen Citrate Generic | 22 | 48 | Under 11 | $1,020 |
| Lenalidomide Generic | 21 | 21 | Under 11 | $271K |
| Dexamethasone Generic | 21 | 21 | Under 11 | $221 |
| Enhertu Fam-Trastuzumab Deruxtecn-Nxki | 20 | 20 | Under 11 | $238K |
| Kisqali Ribociclib Succinate | 19 | 19 | Under 11 | $340K |
Brand drugs: 572 claims; generic drugs: 691 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roger Febres $57.88 ($57.88 in general payments such as food, travel and fees) from 2 companies. The largest payer was Incyte Corporation with $39.8.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 2 | $39.8 |
| Menarini Silicon Biosystems, Inc. | 1 | $18.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.